Tart cherry was associated withĪ significant reduction in insomnia severity (minutes awake after sleep onset), but no significant improvements in sleep Assessment was based on sleep diary data and an insomnia severity index. Participants took treatment or placebo for two weeks, with a two week intervening In 15 older adults with chronic insomnia. Another randomised, double-blind, placebo-controlled, crossover study investigated the effect of tart cherry extract.Non-significant reductions in time taken to fall asleep (sleep latency - approximately five minutes) and wake after sleep On sleep diary data, participants had a significant increase in total sleep time when taking tart cherry extract, and A randomised, double-blind, placebo-controlled, crossover study investigated twenty healthy adults who consumed tartĬherry concentrate or placebo within 30 minutes of waking and 30 minutes before their evening meal, for seven days.To date, there has been limited clinical research investigating the effect of cherry extracts on sleep. 1 They also contain anti-inflammatory cytokines and melatonin, which if absorbed, may Tart cherries contain various phytochemicals, including anthocyanins, which are reported to have cellular oxidative stress Montmorency tart cherries, which are a variety of amarelle, are the most common constituent of “medicinal” cherry products. There are two main types of tart cherries – morello and amarelle. 1 CherriesĪre generally divided into sweet or tart varieties.

Such as improving sleep, reducing muscle recovery time after exercise and decreasing inflammation. It is claimed that cherries and cherry extracts, particularly tart cherry, are associated with several health benefits,

In most situations, throat swabbing and antibiotic treatment in populations at low risk of acute rheumatic fever should Where this might be appropriate are relatively uncommon, but could include the scenario described by our correspondent. Then further consideration should be given to isolating them for 24 hours after starting antibiotics. healthcare and residential care workers, food handlers, teachers andĬhildcare workers, 1 who present with symptoms consistent with GAS pharyngitis. Of spreading GAS to vulnerable populations, e.g. The New Zealand National Heart Foundation recommends considering throat swabbing and treating workers at increased risk

Of transmission of GAS infection are estimated to be up to 25% to the close contacts of people with active GAS infections. GAS throat infection is highly transmissible by droplet spread. However, there are exceptions to every rule. 1 This is because the risk of increasing antimicrobial resistance and the possible adverseĮffects associated with the use of antibiotics are judged to exceed any benefits provided by the prophylaxis of rheumatic 2 Therefore in populations at low risk of developingĪcute rheumatic fever, throat swabbing and antibiotic prescribing for group A streptococcal (GAS) pharyngitis is generally From January 2002 to December 2011, 80% of patients diagnosed with acute rheumatic fever in the WaikatoĭHB were Māori and 92% were aged between five and 19 years. Peoples, 1 and that the majority of cases of rheumatic fever in New Zealand occur in people aged between fiveĪnd 19 years. This advice is based on the observation that acute rheumatic fever is extremely uncommon in non-Māori and non-Pacific

Was: “Do not prescribe an antibiotic for patients with a sore throat who are not of Māori or Pacific ethnicity Simple changes to antibiotic prescribing for health professionals to improve antimicrobial stewardship. In the “Upfront” article in the antibiotic issue, BPJ 68 (Jun, 2015), Associate Professor Mark Thomas recommended three

Low dosage tart cherry pills